Building evidence on safety of endovascular thrombectomy for patients under anticoagulation with vitamin K antagonists
- PMID: 38958388
- PMCID: PMC11220830
- DOI: 10.1111/cns.14777
Building evidence on safety of endovascular thrombectomy for patients under anticoagulation with vitamin K antagonists
Abstract
A recent study by Brian Mac Grory and colleagues investigated the safety of endovascular thrombectomy (EVT) among patients under vitamin K antagonists (VKAs) use within 7 days prior to hospital admission. Through this retrospective, observational cohort study, they found prior VKA use did not increase the risk of symptomatic intracranial hemorrhage (sICH) overall. However, recent VKA use with a presenting international normalized ratio (INR) > 1.7 was associated with a significantly increased risk of sICH. Future large-scale randomized controlled trials should be conducted to further clarify the effects and feasibility of EVT therapy in ischemic stroke patients under anticoagulation.
Keywords: anticoagulation; endovascular thrombectomy; ischemic stroke; symptomatic intracranial hemorrhage; vitamin K antagonists.
© 2024 The Author(s). CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the authorship, and/or publication of this article. Peiying Li is an Editorial Board member of CNS Neuroscience and Therapeutics and a co‐author of this article. To minimize bias, they were excluded from all editorial decision‐making related to the acceptance of this article for publication.
Comment on
-
Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic Stroke.JAMA. 2023 Jun 20;329(23):2038-2049. doi: 10.1001/jama.2023.8073. JAMA. 2023. PMID: 37338878 Free PMC article.
References
-
- Rebello LC, Haussen DC, Belagaje S, Anderson A, Frankel M, Nogueira RG. Endovascular treatment for acute ischemic stroke in the setting of anticoagulation. Stroke. 2015;46(12):3536‐3539. - PubMed
-
- Rozeman AD, Wermer MJH, Lycklama À, et al. Safety of intra‐arterial treatment in acute ischaemic stroke patients on oral anticoagulants. A cohort study and systematic review. Eur J Neurol. 2016;23(2):290‐296. - PubMed
-
- L'Allinec V, Ernst M, Sevin‐Allouet M, et al. Safety and efficacy of mechanical thrombectomy in acute ischemic stroke of anticoagulated patients. J Neurointerv Surg. 2018;10(12):e29. - PubMed
-
- Goldhoorn R‐JB, van de Graaf RA, van Rees JM, et al. Endovascular treatment for acute ischemic stroke in patients on oral anticoagulants: results from the MR CLEAN registry. Stroke. 2020;51(6):1781‐1789. - PubMed
-
- L'Allinec V, Sibon I, Mazighi M, et al. MT in anticoagulated patients: direct oral anticoagulants versus vitamin K antagonists. Neurology. 2020;94(8):e842‐e850. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 81971096/National Natural Science Foundation of China
- 81801298/National Natural Science Foundation of China
- 82061130224/National Natural Science Foundation of China
- 91957111/National Natural Science Foundation of China
- M-0671/National Natural Science Foundation of China
- U22A20295/National Natural Science Foundation of China
- SHDC12019102/New Frontier Technology Joint Research sponsored by Shanghai Shenkang Hospital Development Center
- 20181805/Shanghai Municipal Education Commission-Gaofeng Clinical Medical
- 20SG17/Shanghai Education Development Foundation and Shanghai Municipal Education Commission
- 20XD1422400/Shanghai Municipal Science and Technology Committee
- NAF/R11/1010/UK Academy of Medical Sciences
- SHSMU-ZLCX20211602/Innovative Research Team of High-level Local Universities in Shanghai
LinkOut - more resources
Full Text Sources
Medical
